Question 1

What is Pasithea Therapeutics?

Accepted Answer

Pasithea Therapeutics is a Company.

Question 2

How often does Pasithea Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 8 articles.

Question 3

When was Pasithea Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Jun 02, 2026.

Question 4

When was Pasithea Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 02, 2026.

Question 5

What is Pasithea Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Pasithea Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Pasithea Therapeutics?

Accepted Answer

Pasithea PAS-004 gets FDA Orphan Drug (Jun 02, 2026, 8 articles).

Question 8

How did the "Pasithea PAS-004 gets FDA Orphan Drug" event impact Pasithea Therapeutics?

Accepted Answer

Pasithea Therapeutics received Orphan Drug Designation for its drug candidate PAS-004, which could provide significant benefits like tax credits, fee exemptions, and market exclusivity, positively impacting its stock and development efforts.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.